LYDNEY PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: L84011 | LYDNEY, GL15 5NQ
Showing results 351-400 of 597
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 48 | 1,510 | £1.2K | +84.2% ▲ | |
| Glycopyrronium/formoterol | 47 | 47 | £1.4K | +85.8% ▲ |
| Betamethasone sodium phosphate | 47 | 610 | £133 | +81.4% ▲ |
| 47 | 6,401 | £491 | -44.8% ▼ | |
| 47 | 1,770 | £2.3K | +188.0% ▲ | |
| Fludrocortisone acetate | 46 | 1,007 | £143 | -56.4% ▼ |
| Norethisterone | 46 | 2,811 | £461 | -5.2% ▼ |
| 46 | 1,795 | £81 | -7.8% ▼ | |
| 46 | 706 | £10.5K | +28.8% ▲ | |
| Vortioxetine | 45 | 1,134 | £1.1K | -35.2% ▼ |
| Prucalopride | 44 | 1,232 | £705 | +13.0% ▲ |
| Ivabradine | 44 | 2,464 | £482 | -53.7% ▼ |
| Tranexamic acid | 44 | 2,442 | £162 | -48.1% ▼ |
| Estradiol valerate | 44 | 1,680 | £139 | +125.3% ▲ |
| Powder amino acid formula (0913107) | 44 | 112.8K | £6.9K | +33.3% ▲ |
| Terbutaline sulphate | 43 | 47 | £371 | -20.7% ▼ |
| Exemestane | 43 | 1,290 | £256 | +32.3% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 43 | 208.6K | £2.6K | -65.3% ▼ |
| Powder preterm infant formula (0913111) | 43 | 115.2K | £1.9K | +170.0% ▲ |
| 43 | 65 | £1.2K | +168.8% ▲ | |
| 43 | 3,064 | £180 | +15.1% ▲ | |
| Levonorgestrel | 42 | 42 | £3.3K | +11.3% ▲ |
| Typhoid | 42 | 42 | £417 | -53.4% ▼ |
| 42 | 1,205 | £206 | +40.6% ▲ | |
| Carmellose sodium | 41 | 3,390 | £538 | -36.7% ▼ |
| Coal tar | 41 | 10.2K | £213 | -43.7% ▼ |
| 41 | 426 | £605 | +201.8% ▲ | |
| Clonazepam | 40 | 1,000 | £112 | -74.3% ▼ |
| Duloxetine hydrochloride | 40 | 1,344 | £268 | -21.9% ▼ |
| Bicalutamide | 40 | 1,078 | £70 | +23.6% ▲ |
| Chlorhexidine gluconate | 40 | 17.3K | £319 | +35.5% ▲ |
| Lisdexamfetamine dimesylate | 39 | 1,120 | £2.8K | -67.3% ▼ |
| Desmopressin acetate | 39 | 3,332 | £2.1K | -25.2% ▼ |
| 39 | 430 | £1.4K | +228.9% ▲ | |
| Ketone blood testing reagents | 38 | 800 | £761 | -43.8% ▼ |
| Vitamin B compound | 38 | 2,478 | £73 | -72.7% ▼ |
| Umeclidinium bromide | 37 | 37 | £965 | -40.0% ▼ |
| Valproic acid | 37 | 2,400 | £767 | -57.5% ▼ |
| Erythromycin | 37 | 1,436 | £592 | +6.8% ▲ |
| Denosumab | 37 | 37 | £6.9K | +36.0% ▲ |
| 37 | 498 | £3.3K | +33.0% ▲ | |
| Lacosamide | 36 | 1,848 | £279 | -33.0% ▼ |
| Midazolam hydrochloride | 36 | 129 | £2.9K | +149.8% ▲ |
| Celecoxib | 36 | 2,106 | £113 | -45.5% ▼ |
| Hydrocortisone acetate | 36 | 1,080 | £206 | -45.5% ▼ |
| Hydralazine hydrochloride | 35 | 2,156 | £111 | -17.1% ▼ |
| Colestyramine | 35 | 2,360 | £1.2K | +21.5% ▲ |
| Adrenaline | 35 | 71 | £4.1K | -44.5% ▼ |
| Nortriptyline | 35 | 1,592 | £49 | -75.9% ▼ |
| Trihexyphenidyl hydrochloride | 35 | 2,184 | £115 | +23.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.